NCT07480902 2026-03-18
Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
Timser SAPI de CV
Phase NA Recruiting
Clinical Trials
8 trialsNCT07211204 2026-03-03
Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
Timser SAPI de CV
Phase NA Withdrawn
NCT07281599 2026-02-02
EQUIP
Qurasense
Phase NA Recruiting
NCT02634190 2024-02-28
Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens
Hologic Deutschland GmbH
Completed
NCT01234480 2023-05-16
Intended Use Study of the BD SurePath Plusâ„¢ Pap
Becton, Dickinson and Company
Terminated
NCT02267876 2021-02-08
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens
Becton, Dickinson and Company
Completed
NCT01944722 2018-06-12
Clinical Evaluation of the BD Onclarityâ„¢ HPV Assay on the BD Viperâ„¢ LT System With Cervical Specimens
Becton, Dickinson and Company
Phase NA Completed
NCT03020121 2018-01-31
Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples
Becton, Dickinson and Company
Phase NA Terminated